105 related articles for article (PubMed ID: 8790223)
1. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.
Ballinger JR; Bannerman J; Boxen I; Firby P; Hartman NG; Moore MJ
J Nucl Med; 1996 Sep; 37(9):1578-82. PubMed ID: 8790223
[TBL] [Abstract][Full Text] [Related]
2. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors.
Ballinger JR; Muzzammil T; Moore MJ
J Nucl Med; 1997 Dec; 38(12):1915-9. PubMed ID: 9430469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
5. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Al-Saeedi FJ; Bitar M; Pariyani S
J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors.
Muzzammil T; Moore MJ; Ballinger JR
Cancer Biother Radiopharm; 2000 Aug; 15(4):339-46. PubMed ID: 11041018
[TBL] [Abstract][Full Text] [Related]
7. Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2004 Aug; 19(4):411-21. PubMed ID: 15453956
[TBL] [Abstract][Full Text] [Related]
8. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470
[TBL] [Abstract][Full Text] [Related]
9. Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.
Perek N; Denoyer D; Dubois F; Koumanov F
Gen Physiol Biophys; 2002 Dec; 21(4):381-404. PubMed ID: 12693711
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
[TBL] [Abstract][Full Text] [Related]
11. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H
J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728
[TBL] [Abstract][Full Text] [Related]
12. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-Tetrofosmin.
Perek N; Koumanov F; Denoyer D; Boudard D; Dubois F
Cancer Biother Radiopharm; 2002 Jun; 17(3):291-302. PubMed ID: 12136521
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line.
Li XF; Kinuya S; Yokoyama K; Konishi S; Ma YY; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Cancer Biother Radiopharm; 2001 Feb; 16(1):17-23. PubMed ID: 11279794
[TBL] [Abstract][Full Text] [Related]
15. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
18. 99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.
Ballinger JR; Hua HA; Berry BW; Firby P; Boxen I
Nucl Med Commun; 1995 Apr; 16(4):253-7. PubMed ID: 7624105
[TBL] [Abstract][Full Text] [Related]
19. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
[TBL] [Abstract][Full Text] [Related]
20. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
Ballinger JR
Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
